《新股表現》普樂師(02486.HK)暗盤低開5.7%報10元
根據輝立交易平台顯示,明天掛牌的普樂師集團(02486.HK)暗盤低開5.7%報10元獲承接,最高見10.72元,現報10.62元,較上市價10.6元,高0.2%,成交53萬股。
普樂師是中國知名銷售及營銷服務供應商。是次在港上市共發2,500萬股,其中10%公開發售獲1.2倍超購,人人有份,股份以招股範圍(10.6-11.8元)下限定價,料集資淨額約2.12億元,主要用作提升核心技術能力和基礎研發、戰略投資和收購合作、提高銷售與營銷及業務發展能力,以及還債等。上市聯席保薦人分別為富瑞及國泰君安國際。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.